Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals )
Location
Weena 800 22nd Floor,
Rotterdam, 3014 DA,
Netherlands
Website
https://www.dsm-sinochem.com/
Phone
31 15 279 91 11
Artw industry
Life Sciences
Employee
Revenue

Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) Technographics

Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) Software Purchases and Digital Transformation Initiatives

Discover the latest software purchases and digital transformation initiatives being undertaken by Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 2000 Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) has purchased the following applications: Microsoft Azure Cloud Services for Application Hosting and Computing Services in 2014, Microsoft 365 for Collaboration in 2015, Mimecast Email Security for Secure Email Gateways (SEGs) in 2019 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) is running and its propensity to invest more and deepen its relationship with Microsoft , Cato Networks , Mimecast or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) revenues, which have grown to $498.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.

Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) Data, Technology Stack, and Enterprise Applications
IaaS
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Microsoft Legacy Microsoft Azure Cloud Services Application Hosting and Computing Services IaaS n/a 2014 2014
SD-WAN IaaS 2017 2018
Collaboration
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2015 2015
CyberSecurity
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Mimecast Legacy Mimecast Email Security Secure Email Gateways (SEGs) CyberSecurity n/a 2019 2019
IT Decision Makers and Key Stakeholders at Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals )
First Name Last Name Title Function Department Email Phone
No data found
Show All Contacts
Apps Being Evaluated by Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) Technographics

Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) is a Life Sciences organization based in Netherlands, with around 2000 employees and annual revenues of $498.0 million.

Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) operates a diverse technology stack with applications such as Microsoft Azure Cloud Services, Microsoft 365 and Mimecast Email Security, covering areas like Application Hosting and Computing Services, Collaboration and Secure Email Gateways (SEGs).

Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft and Mimecast.

Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) recently adopted applications including Mimecast Email Security in 2019, Cato Secure SD-WAN in 2017 and Microsoft 365 in 2015, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals )’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals )’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Centrient Pharmaceuticals ( ex DSM Sinochem Pharmaceuticals ) technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.